rs398124560
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_183050.4(BCKDHB):c.1006G>A(p.Gly336Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000274 in 1,461,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_183050.4 missense
Scores
Clinical Significance
Conservation
Publications
- maple syrup urine disease type 1BInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, G2P, Myriad Women’s Health
- maple syrup urine diseaseInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- classic maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- intermediate maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- intermittent maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- thiamine-responsive maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BCKDHB | NM_183050.4 | c.1006G>A | p.Gly336Ser | missense_variant | Exon 9 of 10 | ENST00000320393.9 | NP_898871.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BCKDHB | ENST00000320393.9 | c.1006G>A | p.Gly336Ser | missense_variant | Exon 9 of 10 | 1 | NM_183050.4 | ENSP00000318351.5 | ||
| BCKDHB | ENST00000356489.9 | c.1006G>A | p.Gly336Ser | missense_variant | Exon 9 of 11 | 1 | ENSP00000348880.5 | |||
| BCKDHB | ENST00000468520.1 | n.236G>A | splice_region_variant, non_coding_transcript_exon_variant | Exon 3 of 3 | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 250950 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461324Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726954 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Maple syrup urine disease Pathogenic:3
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 336 of the BCKDHB protein (p.Gly336Ser). This variant is present in population databases (rs398124560, gnomAD 0.006%). This missense change has been observed in individual(s) with maple syrup urine disease (PMID: 28417071, 28830848, 31112740). ClinVar contains an entry for this variant (Variation ID: 96562). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt BCKDHB protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.
Maple syrup urine disease type 1B Pathogenic:3
Variant summary: BCKDHB c.1006G>A (p.Gly336Ser) results in a non-conservative amino acid change located in the C-terminal domain (IPR033248) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251350 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1006G>A has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with Maple Syrup Urine Disease Type 1B (e.g., Imtiaz_2017, Cheng_2017). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 28830848, 28417071). Five submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic (n = 1) or likely pathogenic (n = 4). Based on the evidence outlined above, the variant was classified as pathogenic.
Maple syrup urine disease type 1A Pathogenic:2
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
not provided Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at